Immunex Message Board - Msg: 9447453

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunex

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Guy Gordon who wrote (314)	5/10/1999 5:18:00 PM
From: Nelson Chang	of 656

NEWS for Monday May 10 after the close: ~Immunex to seek expanded label for Enbrel - Reuters Securities - 4:49 pm ~Immunex and Wyeth Ayerst Announce Label Update for ENBREL(R) - PR Newswire - 4:11 pm ~Alert: Immunex Says Plans to Seek Expanded Label for Enbrel in Q3 - Reuters Securities - 4:10 pm ~Alert: Immunex Says Results Positive in Enbrel Trial for Early Arthritis - Reuters Securities - 4:09 pm ~Positive Results of Pivotal Phase III Trial With ENBREL(R) in Patients With Early, Active Rheumatoid Arthritis - PR Newswire - 4:04 pm The Yahoo link is at biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next